Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Sepiapterin reductase deficiency: Report of 5 new cases.
|
28189489 |
2017 |
Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia.
|
11443547 |
2001 |
Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Sepiapterin reductase deficiency: a treatable mimic of cerebral palsy.
|
22522443 |
2012 |
Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Sepiapterin reductase deficiency: a treatable mimic of cerebral palsy.
|
22522443 |
2012 |
Intellectual Disability
|
0.400 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia.
|
16650784 |
2006 |
Dopa-Responsive Dystonia
|
0.370 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Sepiapterin reductase deficiency: a treatable mimic of cerebral palsy.
|
22522443 |
2012 |
Dopa-Responsive Dystonia
|
0.370 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Dopa-Responsive Dystonia
|
0.370 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Sepiapterin reductase deficiency: a treatable mimic of cerebral palsy.
|
22522443 |
2012 |
Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Dopa-responsive hypersomnia and mixed movement disorder due to sepiapterin reductase deficiency.
|
17159114 |
2006 |
Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia.
|
16650784 |
2006 |
Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia.
|
11443547 |
2001 |
Bipolar Disorder
|
0.310 |
Biomarker
|
disease |
PSYGENET |
This reduced transcription rate for SPR promoter haplotypes 2 and 3 may impact on BH4-mediated neurotransmitter production, thus suggesting a biological process through which SPR gene variants might influence antidepressant response and susceptibility to bipolar disorder.
|
19415819 |
2009 |
Mood Disorders
|
0.310 |
Biomarker
|
group |
PSYGENET |
We tested for association of SPR promoter polymorphisms with antidepressant response in a well-characterized triad cohort of mood disorders.
|
19415819 |
2009 |
Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency
|
0.710 |
GermlineCausalMutation
|
disease |
ORPHANET |
|
|
|
Intellectual Disability
|
0.400 |
Biomarker
|
group |
HPO |
|
|
|
Cerebral Palsy
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Aggressive behavior
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Blepharoptosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Drowsiness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dystonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyperhidrosis disorder
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Microcephaly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|